Tenax Therapeutics, Inc. (TENX)
2.19
+0.34
(+18.38%)
USD |
NASDAQ |
Aug 25, 10:38
Tenax Therapeutics Shareholders Equity (Quarterly) : 113.59M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 113.59M |
| March 31, 2026 | 114.69M |
| December 31, 2025 | 97.07M |
| September 30, 2025 | 96.21M |
| June 30, 2025 | 103.33M |
| March 31, 2025 | 109.29M |
| December 31, 2024 | 91.99M |
| September 30, 2024 | 97.22M |
| June 30, 2024 | 8.876M |
| March 31, 2024 | 12.43M |
| December 31, 2023 | 8.098M |
| September 30, 2023 | 11.29M |
| June 30, 2023 | 13.22M |
| March 31, 2023 | 14.28M |
| December 31, 2022 | 1.493M |
| September 30, 2022 | 3.954M |
| June 30, 2022 | 6.784M |
| March 31, 2022 | 1.606M |
| December 31, 2021 | 4.245M |
| September 30, 2021 | 7.239M |
| June 30, 2021 | 1.471M |
| March 31, 2021 | 3.096M |
| December 31, 2020 | 4.626M |
| September 30, 2020 | 7.404M |
| June 30, 2020 | 3.029M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.419M |
| December 31, 2019 | 3.772M |
| September 30, 2019 | 6.536M |
| June 30, 2019 | 8.620M |
| March 31, 2019 | 10.34M |
| December 31, 2018 | 11.77M |
| September 30, 2018 | 4.938M |
| June 30, 2018 | 6.233M |
| March 31, 2018 | 8.001M |
| December 31, 2017 | 8.882M |
| September 30, 2017 | 10.16M |
| June 30, 2017 | 11.27M |
| March 31, 2017 | 14.11M |
| December 31, 2016 | 17.14M |
| September 30, 2016 | 46.69M |
| June 30, 2016 | 50.89M |
| April 30, 2016 | |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | 67.37M |
| April 30, 2015 | 70.43M |
| January 31, 2015 | 75.36M |
| October 31, 2014 | 77.59M |
| July 31, 2014 | 81.54M |
| April 30, 2014 | 82.89M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Exicure, Inc. | 0.977M |
| Century Therapeutics, Inc. | 232.34M |
| Absci Corp. | 246.13M |
| Celularity, Inc. | -38.06M |
| Cardio Diagnostics Holdings, Inc. | 7.426M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 121.66M |
| Total Liabilities (Quarterly) | 8.073M |
| Current Ratio | 15.07 |